Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IK-3001 in Peri-operative Pulmonary Hypertension
NCT01959828Phase 3Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Sep 2013
- Primary completion
- Mar 2014
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of nitric oxide in pulmonary hypertension (PH), sponsored by Mallinckrodt Pharmaceuticals. Started Sep 2013; status: completed.
02
Drugs
nitric oxide
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01959828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01959828.